Merck to Buy Terns for $6.7B Merck agreed to acquire Terns for $6.7B on Mar 25, 2026 (Bloomberg); the deal is a focused bet on a leukemia asset as Merck seeks pipeline replenishment.

Merck to Buy Terns for $6.7B: Merck agreed to acquire Terns for $6.7B on Mar 25, 2026 (Bloomberg); the deal is a focused bet on a leukemia asset as Merck seeks pipeline replenishment. 👈 Read full analysis #Merck #TernsPharmaceuticals #Acquisition #Leukemia #Pharmaceuticals

Le géant pharmaceutique Merck rachète Terns Pharmaceuticals pour 6,7 milliards de dollars Principaux renseignements Merck, un géant pharmaceutique, rachète Terns Pharmaceuticals pour 6,7 milliards de dollars (5,7 milliards d’euros) dans le cadre d’une transaction entièrement en numéraire. C’est ce qu’a annoncé la société mercredi. Cette acquisition intervient alors que Merck souhaite renforcer son portefeuille de médicaments avant que son médicament anticancéreux à succès, Keytruda, ne perde sa […]

Le géant pharmaceutique Merck rachète Terns Pharmaceuticals pour 6,7 milliards de dollars #Pharmaceutique #Merck #TernsPharmaceuticals #Acquisition #Médicaments

Farmareus Merck neemt Terns Pharmaceuticals over voor 6,7 miljard dollar Key takeaways Merck, een farmaceutische gigant, neemt Terns Pharmaceuticals over voor 6,7 miljard dollar (5,7 miljard euro) in een volledig contante transactie. Dat liet het bedrijf woensdag weten. De overname komt op een moment dat Merck zijn geneesmiddelenportfolio wil versterken voordat zijn succesvolle kankermedicijn, Keytruda, in 2028 zijn octrooibescherming verliest. Merck neemt Terns over voor […]

Farmareus Merck neemt Terns Pharmaceuticals over voor 6,7 miljard dollar #Merck #TernsPharmaceuticals #farmacie #overname #kankerbehandeling

Merck Buys Terns for $6.7bn to Fortify Oncology Merck will acquire Terns for $6.7bn (announced Mar 25, 2026) as Keytruda faces patent loss in 2028; the deal recalibrates Merck's oncology pipeline strategy.

Merck Buys Terns for $6.7bn to Fortify Oncology: Merck will acquire Terns for $6.7bn (announced Mar 25, 2026) as Keytruda faces patent loss in 2028; the deal recalibrates Merck's oncology pipeline… 👈 Read full analysis #Merck #TernsPharmaceuticals #Oncology #Pharmaceuticals #MergersAndAcquisitions

Merck Nears Deal to Buy Terns Pharmaceuticals Bloomberg reported on Mar 25, 2026 that Merck is in advanced talks to acquire Terns Pharmaceuticals; watch filings and deal structure for valuation impacts.

Merck Nears Deal to Buy Terns Pharmaceuticals: Bloomberg reported on Mar 25, 2026 that Merck is in advanced talks to acquire Terns Pharmaceuticals; watch filings and deal structure for valuation impacts. 👈 Read full analysis #Merck #TernsPharmaceuticals #Biotech #MergersAndAcquisitions #PharmaNews